proteina 150-170 mg corresp. immunoglobulinum humanum normale 95 % m/V corresp. hepatitidis A virus antigenum min. 100 U.I., immunoglobulinum A max. 1.7 mg, glycinum, natrii chloridum, aqua ad iniectabilia q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injektionslösung zur intramuskulären Anwendung
Active Agent
Dose
Hepatitidis a Virus Antigenum
Immunoglobulinum Humanum Normale
95 % m/V correspond Hepatitidis a Virus Antigenum min. 100 UI
Source
Data was imported : 08.07.2014
Swissmedic Registration : 00672
Sequence : 01
Product name : Beriglobin, Injektionslösung zur intramuskulären Anwendung
Registration owner: : CSL Behring AG
Product group :
Index Therapeuticus (BSV) : 08.09.
Medication Code : Blutprodukte
Date of registration : 23.05.2005
Valid until : 23.02.2020
Package number : 040
Show package size : 1
Commercial Form/Unit : Spritze(n)
Swissmedic categorie. : B
Active Agents : immunoglobulinum humanum normale, hepatitidis A virus antigenum
Composition : proteina 150-170 mg corresp. immunoglobulinum humanum normale 95 % m/V corresp. hepatitidis A virus antigenum min. 100 U.I., immunoglobulinum A max. 1.7 mg, glycinum, natrii chloridum, aqua ad iniectabilia q.s. ad solutionem pro 1 ml.
